AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT
Search National Drug Schedules Member Login

What's New

NAPRA's 20th Anniversary / 20e anniversaire de l'ANORP

Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules

Please note, this section will be updated periodically as the information becomes available.


  Reminder: Courses and PLAR exams available in both English and French

    NOTE: Selkirk College registration deadline for all English and French courses beginning in September 2015 is August 27, 2015


        Rappel :  Les cours et les examens ERA sont offerts en français et en anglais

  REMARQUE :  La date limite pour l’inscription aux cours (anglais et français) débutant en septembre 2015 au collège Selkirk est le 27 août 2015


Registration deadlines for all institutions are available on the Course and PLAR Schedules page.

Registration for all courses is conducted directly with the educational institution offering the program.

NDSAC Meeting of September 13-14, 2015

The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for September 13-14, 2015 is cancelled.

The next meeting of the Committee is scheduled for December 6-7, 2015. The deadline to receive submissions for a drug scheduling application for this meeting is by end of day Wednesday, October 7, 2015.

Health Product Risk Communication

Gluconorm (repaglinide) – New Contraindication for Concomitant Use with Clopidogrel

Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction.

Health Canada communication

Information Update

Nosodes and children’s cough, cold and flu homeopathic products Labelling Changes

Health Canada is advising consumers that it is introducing label changes for certain homeopathic products that fall under the Natural Health Product Regulations (NHPR). More particularly, Health Canada is requesting the addition of statements on homeopathic nosode products to make it clear that they are not vaccines or alternatives to vaccines to improve the safe use of these products.

Health Canada Information Update

Health Product InfoWatch

The July issue of the Health Product InfoWatch published by Health Canada is now available. This monthly publication provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products. Please
consult the index for a complete listing of previous issues.

Information Update

Unauthorized natural health product “Remogen”
containing ibogaine and the risk of abnormal heart rhythms

Health Canada is advising Canadians that it has received a serious domestic adverse reaction report of abnormal heart rhythms associated with the ingestion of “Remogen” (containing ibogaine), an unauthorized natural health product in Canada that may pose serious health risks. Canadians who have used this product and have concerns about their health should speak with their healthcare practitioner.

Health Canada Information Update

Health Canada Advisory

Recall of Additional Lots of NaturaLyte Sodium
Bicarbonate Liquid Concentrate due to Potential Bacterial Contamination

Specific lots of NaturaLyte Sodium Bicarbonate Liquid
Concentrate in 6.4 L volumes that may contain higher bacterial levels than
acceptable are being recalled by Fresenius Medical Care, in consultation with
Health Canada.

Health Canada Advisory 

Health Canada Advisory

Unauthorized eye drops seized from two Richmond, B.C.

Health Canada is informing Canadians that five brands of unauthorized eye drops
labelled to contain a prescription drug (neostigmine methylsulfate) have been
seized from two retailers, Cube Inc. and Magic Queen Cosmetics in Richmond,
B.C. (Aberdeen Centre 4151 Hazelbridge Way). These products may pose serious
risks to the health of Canadians.

Health Canada Advisory

Health Product Risk Communication

Vancomycin Hydrochloride Injection USP, 1g/vial- SteriMax

A label error has been identified on one lot (Lot# BK112A14) of SteriMax Vancomycin HCl Injection, 1g/vial. This error is only found on the French text of the outer carton’s reconstitution instructions. The information found on the vial label and package insert correctly indicates the dosing information.

Health Canada Health Product Risk Communication

Information Update

Health Canada taking new action to improve acetaminophen safety, reminds Canadians about safe use.

Health Canada is taking additional steps to minimize the risk of liver damage and improve acetaminophen safety. This action is in light of a Health Canada review that assessed acetaminophen and liver injury in the Canadian context, a summary of which is available on Health Canada’s website.

Health Canada Information Update



Gateway for international
Portail pour pharmaciens
formés à l’étranger




National Pharmacy Technician Bridging Education Program

Students and educational institutions can find more information about NAPRA's newest program.

NDSAC Drug Scheduling Applications

Find information about the NDSAC process and how to prepare scheduling applications.


Blueprint for Pharmacy

Want to learn more? Click here to visit the website!